The FDA recommended back in 2010 that IVC filters be eliminated as soon at the risk passed and in 2014 repeated this communication, adding that filter pieces could migrate within the body. And judging from the increasing number of IVC Filter lawsuits, including two inferior vena cava (IVC) filter class actions in Canada, the device may soon be pulled from the market.
In recent years many manufacturers have created these devices to be retrievable, while older models were meant to be permanent. The cage-like design is supposed to trap and break up blood clots and at the same time allow the rest of the blood to flow freely. But with the “rest” of the blood, there could be minute pieces of the device breaking off from the cage structure and migrating to other parts of the body.To know more about ivc filters you can browse http://www.bardfilterlawsuitcenter.com/sacramento-bard-filter-lawyer/.
In the US, most lawsuits have been filed against IVC filter manufacturers C.R. Bard, Cook Medical, and Cordis. These three companies combined account for 75 percent of the IVC filter market. Bard was one of the first companies hit with a lawsuit: Lisa Davis was implanted with its G2 filter in 2006 and two years later it fractured and migrated to her heart.
Davis chose not to have open heart surgery to separate the filter fragment; instead, she opted to take blood thinners for the rest of her life. Davis is suing Bard for failing to warn her physician of the IVC filter’s risks and misled the device as safe. She sued for physical trauma, anxiety and impaired ability to earn wages.